Report Detail

Other Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2019-2025

  • RnM3411721
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Other

Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Paracetamol
      • 1.4.3 Ibuprofen
      • 1.4.4 Aspirin
      • 1.4.5 Naproxen
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size
    • 2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
      • 2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2014-2025)
      • 2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Manufacturers
      • 3.1.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
    • 3.3 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product/Solution/Service
    • 3.4 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2014-2019)
    • 4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in United States
    • 5.3 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 5.4 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    6 Europe

    • 6.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe
    • 6.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 6.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    7 China

    • 7.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China
    • 7.3 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 7.4 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    8 Japan

    • 8.1 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan
    • 8.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 8.4 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia
    • 9.3 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 9.4 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    10 India

    • 10.1 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India
    • 10.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 10.4 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America
    • 11.3 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 11.4 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.1.5 Novartis Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Boehringer Ingelheim
      • 12.3.1 Boehringer Ingelheim Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.3.5 Boehringer Ingelheim Recent Development
    • 12.4 Teva Pharmaceutical
      • 12.4.1 Teva Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.4.5 Teva Pharmaceutical Recent Development
    • 12.5 Hospira
      • 12.5.1 Hospira Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.5.5 Hospira Recent Development
    • 12.6 Lonza Group
      • 12.6.1 Lonza Group Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.6.5 Lonza Group Recent Development
    • 12.7 Mylan
      • 12.7.1 Mylan Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.7.5 Mylan Recent Development
    • 12.8 Aurobindo Pharma
      • 12.8.1 Aurobindo Pharma Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.8.5 Aurobindo Pharma Recent Development
    • 12.9 Dr. Reddy's Laboratories
      • 12.9.1 Dr. Reddy's Laboratories Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.9.5 Dr. Reddy's Laboratories Recent Development
    • 12.10 Actavis
      • 12.10.1 Actavis Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.10.5 Actavis Recent Development
    • 12.11 Wuxi Apptec
    • 12.12 Zhejiang NHU

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
      North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
      In 2018, the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) development in United States, Europe and China.

      The key players covered in this study
      Novartis
      Pfizer
      Boehringer Ingelheim
      Teva Pharmaceutical
      Hospira
      Lonza Group
      Mylan
      Aurobindo Pharma
      Dr. Reddy's Laboratories
      Actavis
      Wuxi Apptec
      Zhejiang NHU

      Market segment by Type, the product can be split into
      Paracetamol
      Ibuprofen
      Aspirin
      Naproxen
      Others

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) status, future forecast, growth opportunity, key market and key players.
      To present the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Industry analysis & Market Report on Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is a syndicated market report, published as Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,137.42
      4,706.13
      6,274.83
      3,474.24
      5,211.36
      6,948.48
      421,777.20
      632,665.80
      843,554.40
      268,194.03
      402,291.05
      536,388.06
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report